Europe
-
Oral steroid warning for asthma patients
Too many people with severe asthma are at risk through the use of oral steroids, a major European conference will hear today. Read more
-
Backing for asthma triple therapy inhaler
A triple therapy inhaler may be the best way to help patients with severe and uncontrolled asthma, according to the findings of a major international study. Read more
-
Placebos may not be placebo – analysis
Clinical researchers should give more information about placebos – as sometimes they may be more active than described, according to an analysis published today. Read more
-
Prostate surgery sufficient – conference hears
Men who have surgery for prostate cancer do not need post-operative radiotherapy, according to the findings of a major trial. Read more
-
Cancer drug benefits exaggerated – claim
The benefits of new cancer drugs continue to be exaggerated in reporting of key trials, it was alleged today. Read more
-
Cancer therapy response ‘eNose’ test
Researchers have created an ‘electronic nose’ that can effectively predict individual patient responses to immunotherapy, it was announced today. Read more
-
Puberty and menopause link to type 2 diabetes risk
Having a longer menstrual cycle and using the contraceptive pill are linked to an increased risk of developing type 2 diabetes, French researchers claim today (17 September 2019). Read more
-
Hope for diabetes incidence reduction
Annual incidence of type 2 diabetes may have peaked following increasing efforts to tackle obesity and unhealthy eating, a conference heard today. Read more
-
How cancer survival is improving
Cancer survival rates in the UK have improved significantly in the last two decades – but have failed to catch up with other countries, according to a major new analysis. Read more
-
Occasional daytime naps ‘lower heart attack/stroke risk’
A daytime nap up to two times a week could lower the risk of having a heart attack or stroke, Swiss researchers say today. Read more